748 related articles for article (PubMed ID: 27043228)
21. Retrospective analysis of 659 laryngeal squamous cell carcinoma patients treated with open laryngeal function-preserving operations.
Tang D; Tao L; Zhou L; Zhang M; Wu H; Li X; Chen X; Li C; Xie M; Cheng L
Acta Otolaryngol; 2018 Nov; 138(11):1043-1050. PubMed ID: 30776268
[TBL] [Abstract][Full Text] [Related]
22. Thyroid cartilage invasion in laryngeal and hypopharyngeal squamous cell carcinoma treated with total laryngectomy.
Koopmann M; Weiss D; Steiger M; Elges S; Rudack C; Stenner M
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3789-3794. PubMed ID: 27256366
[TBL] [Abstract][Full Text] [Related]
23. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
[TBL] [Abstract][Full Text] [Related]
24. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
25. Oncologic and functional outcomes of salvage supracricoid partial laryngectomy.
Kim JH; Kim WS; Koh YW; Kim SH; Byeon HK; Choi EC
Acta Otolaryngol; 2018 Dec; 138(12):1117-1122. PubMed ID: 30702020
[TBL] [Abstract][Full Text] [Related]
26. Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.
Birkeland AC; Beesley L; Bellile E; Rosko AJ; Hoesli R; Chinn SB; Shuman AG; Prince ME; Wolf GT; Bradford CR; Brenner JC; Spector ME
Head Neck; 2017 Dec; 39(12):2512-2518. PubMed ID: 28963806
[TBL] [Abstract][Full Text] [Related]
27. Lymph node density as an independent predictor of cancer-specific mortality in patients with lymph node-positive laryngeal squamous cell carcinoma after laryngectomy.
Ryu IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
Head Neck; 2015 Sep; 37(9):1319-25. PubMed ID: 24828891
[TBL] [Abstract][Full Text] [Related]
28. Surgery-based versus radiation-based treatment strategy for a high metabolic volume laryngeal cancer.
Yabuki K; Sano D; Shiono O; Arai Y; Chiba Y; Tanabe T; Nishimura G; Takahashi M; Taguchi T; Kaneta T; Hata M; Oridate N
Laryngoscope; 2017 Apr; 127(4):862-867. PubMed ID: 27576793
[TBL] [Abstract][Full Text] [Related]
29. Transoral laser microsurgery in treatment of pT2 and pT3 glottic laryngeal squamous cell carcinoma - results of 391 patients.
Canis M; Martin A; Ihler F; Wolff HA; Kron M; Matthias C; Steiner W
Head Neck; 2014 Jun; 36(6):859-66. PubMed ID: 23720321
[TBL] [Abstract][Full Text] [Related]
30. Organ preservation surgery for laryngeal squamous cell carcinoma: low incidence of thyroid cartilage invasion.
Hartl DM; Landry G; Hans S; Marandas P; Brasnu DF
Laryngoscope; 2010 Jun; 120(6):1173-6. PubMed ID: 20513035
[TBL] [Abstract][Full Text] [Related]
31. Cartilage invasion patterns in laryngeal cancer.
Gómez Serrano M; Iglesias Moreno MC; Gimeno Hernández J; Ortega Medina L; Martín Villares C; Poch Broto J
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1863-9. PubMed ID: 26100029
[TBL] [Abstract][Full Text] [Related]
32. Oncological results of surgical treatment versus organ-function preservation in larynx and hypopharynx câncer.
Calvas OIJ; Ramos DM; Matos LL; Kulcsar MAV; Dedivitis RA; Brandão LG; Cernea CR
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1082-1089. PubMed ID: 29489975
[TBL] [Abstract][Full Text] [Related]
33. Is thyroid excision mandatory with laryngectomy in carcinoma larynx?
Baghel SS; Singhal P; Verma N; Sehra R; Yadav R; Agarwal S; Sharma MP; Gupta DP
BMC Cancer; 2020 Jul; 20(1):700. PubMed ID: 32723304
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.
Rosenthal DI; Mohamed AS; Weber RS; Garden AS; Sevak PR; Kies MS; Morrison WH; Lewin JS; El-Naggar AK; Ginsberg LE; Kocak-Uzel E; Ang KK; Fuller CD
Cancer; 2015 May; 121(10):1608-19. PubMed ID: 25586197
[TBL] [Abstract][Full Text] [Related]
35. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
36. Benefits and drawbacks of open partial horizontal laryngectomies, Part A: Early- to intermediate-stage glottic carcinoma.
Succo G; Crosetti E; Bertolin A; Lucioni M; Caracciolo A; Panetta V; Sprio AE; Berta GN; Rizzotto G
Head Neck; 2016 Apr; 38 Suppl 1():E333-40. PubMed ID: 25581514
[TBL] [Abstract][Full Text] [Related]
37. Oncologic outcomes of total laryngectomy: impact of margins and preoperative tracheostomy.
Basheeth N; O'Leary G; Khan H; Sheahan P
Head Neck; 2015 Jun; 37(6):862-9. PubMed ID: 24623609
[TBL] [Abstract][Full Text] [Related]
38. Supracricoid laryngectomy with cricohyoidoepiglotto-pexy or cricohyoido-pexy: experience on 32 patients.
Nakayama M; Okamoto M; Miyamoto S; Takeda M; Yokobori S; Masaki T; Seino Y
Auris Nasus Larynx; 2008 Mar; 35(1):77-82. PubMed ID: 17869042
[TBL] [Abstract][Full Text] [Related]
39. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone.
Furusaka T; Matuda H; Saito T; Katsura Y; Ikeda M
Acta Otolaryngol; 2012 May; 132(5):546-51. PubMed ID: 22264025
[TBL] [Abstract][Full Text] [Related]
40. Anterior laryngeal commissure: Histopathologic data from supracricoid partial laryngectomy.
Prades JM; Gavid M; Dumollard JM; Timoshenko AT; Karkas A; Peoc'h M
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Feb; 133(1):27-30. PubMed ID: 26778447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
